Join a community of interest
Standards and specifications to electronically share health information consistently, safely and reliably
Support for digital health implementations
Resources and enablers to accelerate clinical interoperability
What's going on in clinical interoperability and digital health
What this site is about, future plans and how to reach us
Share this page:
Welcome,
Guest
|
|
Hello,
My question relates to LOINC/pCLOCD code 46761-3 "Biotinidase deficiency newborn screen interpretation". This test has a Component property of “Biotinidase deficiency”, but a Preferred Answer List with values like “In range”, “Borderline”, “Indeterminate”. What does a “Biotinidase deficiency” of “In range” even mean? The deficiency is “in range” so the Biotinidase level is below normal? Or the Biotinidase level is “in range”, so there is no Biotinidase deficiency? Should the Component here just be “Biotinidase” or perhaps "Biotinidase level"? Also, what happens if a different answer list with values like “Not deficient”, “Deficient”, “Deficient requiring further follow-up testing”, “Deficient requiring immediate intervention” is used? Then a Component of “Biotinidase deficiency” makes sense. So there is ambiguity in how this LOINC could be interpreted, and its sense could be completely inverted depending on the answer list being used. Am I putting too much stock in the Component property and Preferred Answer List? Thoughts/feedback appreciated. Regards, Marc |
The administrator has disabled public write access.
|
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.